Intermediate-stage HCC: Exploring Treatment Options

preview_player
Показать описание
While the classically recommended treatment option for intermediate-stage HCC patients is transarterial chemoembolisation (TACE), this decision should always be made on an individual case basis and other options are worth considering, such as radioembolisation and percutaneous ablation. In this video filmed at ECIO 2017, Prof. Tobias Jakobs, Prof. Riad Salem and Prof. Thomas Helmberger discuss the future of intermediate-stage HCC treatment, with a particular focus on the advances in radioembolisation.

  1. CIRSEsociety
  2. ECIO 2017
  3. European Conference on Interventional Oncology
  4. HCC
  5. Prof. Tobias
  6. Prof. Riad Salem
Рекомендации по теме
Intermediate-stage HCC: Exploring 0:04:34

Intermediate-stage HCC: Exploring Treatment Options

Highlights: Intermediate HCC 0:04:53

Highlights: Intermediate HCC – treatment options and strategies

Intermediate HCC – 0:01:00

Intermediate HCC – treatment options and strategies

Intermediate Hepatocellular Carcinoma 0:20:20

Intermediate Hepatocellular Carcinoma (HCC) – Treatment Options & Strategies

Intermediate HCC – 0:20:20

Intermediate HCC – treatment options and strategies

Exploring New Treatment 0:59:57

Exploring New Treatment Options In HCC

Intermediate HCC – 0:27:13

Intermediate HCC – The evolving role of IO

Highlights: Intermediate HCC 0:05:36

Highlights: Intermediate HCC – The evolving role of IO

Exploring Challenges in 0:01:49

Exploring Challenges in the Treatment of HCC

Evidence-Based Treatment Selection 1:37:24

Evidence-Based Treatment Selection and Sequencing in Advanced HCC

Treatment Options for 0:05:57

Treatment Options for Locally Advanced HCC

Treatment Strategies for 0:06:30

Treatment Strategies for Early-Stage HCC

Curative and Palliative 0:00:52

Curative and Palliative Treatment Options for Patients With Hepatocellular Carcinoma

HCC: Optimizing Outcomes 1:05:05

HCC: Optimizing Outcomes With New and Emerging Treatment Approaches

Mapping the Optimal 1:35:10

Mapping the Optimal Treatment Route in HCC: Best Practices

Emerging Evidence on 0:59:48

Emerging Evidence on Immunotherapy for HCC Management in Intermediate Stages

The HCC Treatment 0:34:21

The HCC Treatment Algorithm: New and Emerging Monotherapy, Combination, and Multimodal Approaches

HCC Staging Systems 0:04:03

HCC Staging Systems Explored

Liver cancer stages 0:10:17

Liver cancer stages - Barcelona clinic - liver cancer staging system - simplified

Dr Franses on 0:02:01

Dr Franses on the Need for Prospective Data in Second-Line HCC and Beyond

Key outcomes of 0:02:40

Key outcomes of the Phase 1b of atezolizumab and bevacizumab for advanced HCC

A New Era 0:29:27

A New Era in Treating Patients with Advanced HCC: 2nd line treatment selection and when to switch?

Systemic therapies for 0:05:44

Systemic therapies for advanced HCC

Treatment Methods and 0:04:31

Treatment Methods and Latest Research in Early-stage HCC